Company

Bio-Techne Receives Shareholders' Approval For Proposed Acquisition By Merck KGaA

Sep 23, 2026 · 09:22 AM ET· updated 2h ago

Bio-Techne Corporation (NASDAQ:TECH) ("Bio-Techne"), a global provider of life science tools, reagents and diagnostic products, announced that Bio-Techne shareholders voted to approve and adopt the definitive

Why It Matters

Bio-Techne shareholders voted yes on being bought by Merck KGaA. This is a major deal milestone, so watch for when it officially closes.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

TECH72.55

-0.00 (-0.01%)

MRK147.71

-3.20 (-2.12%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.